Molecular landscape and actionable alterations in a genomically guided cancer clinical trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI …

KT Flaherty, RJ Gray, AP Chen, S Li… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE Therapeutically actionable molecular alterations are widely distributed across
cancer types. The National Cancer Institute Molecular Analysis for Therapy Choice (NCI …
被引用次数：217 相关文章

Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI …

KT Flaherty, RJ Gray, AP Chen, S Li, LM McShane… - 2020 - jdc.jefferson.edu
PURPOSE: Therapeutically actionable molecular alterations are widely distributed across
cancer types. The National Cancer Institute Molecular Analysis for Therapy Choice (NCI …
[HTML] kanker-actueel.nl

[HTML][HTML] Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy …

KT Flaherty, RJ Gray, AP Chen, S Li, LM McShane… - kanker-actueel.nl
Purpose: Therapeutically actionable molecular alterations are widely distributed across
cancer types. The National Cancer Institute Molecular Analysis for Therapy Choice (NCI …
[HTML] nih.gov

[HTML][HTML] Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy …

KT Flaherty, RJ Gray, AP Chen, S Li… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
PURPOSE Therapeutically actionable molecular alterations are widely distributed across
cancer types. The National Cancer Institute Molecular Analysis for Therapy Choice (NCI …

Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI …

KT Flaherty, RJ Gray, AP Chen, S Li… - Journal of clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Purpose Therapeutically actionable molecular alterations are widely distributed across
cancer types. The National Cancer Institute Molecular Analysis for Therapy Choice (NCI …

Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI …

KT Flaherty, RJ Gray, AP Chen, S Li… - Journal of Clinical …, 2020 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> PURPOSE</jats: title>< jats: p> Therapeutically actionable
molecular alterations are widely distributed across cancer types. The National Cancer …

Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI …

KT Flaherty, RJ Gray, AP Chen, S Li… - Journal of Clinical …, 2020 - europepmc.org
Purpose Therapeutically actionable molecular alterations are widely distributed across
cancer types. The National Cancer Institute Molecular Analysis for Therapy Choice (NCI …
[HTML] kanker-actueel.nl

[HTML][HTML] Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy …

KT Flaherty, RJ Gray, AP Chen, S Li, LM McShane… - kanker-actueel.nl
Purpose: Therapeutically actionable molecular alterations are widely distributed across
cancer types. The National Cancer Institute Molecular Analysis for Therapy Choice (NCI …